Back to Search
Start Over
Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer
- Source :
- Head & Neck. 39:1291-1295
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
-
Abstract
- Background Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) is a quality improvement project aimed at decreasing time from referral to disposition (scheduling of first appointment) to our institution. After identifying reasons for delays, we created a new process flow specifically for patients with ATC allowing patients to be scheduled immediately. Results Historical data revealed a mean referral to disposition time for patients with ATC of 8.7 days before our intervention. After the intervention, the mean referral to disposition time was reduced to 0.5 days. Participation in treatment trials for all patients with ATC was 34%. Conclusion Since the implementation of FAST, the access time has decreased and the number of successful referrals for ATC has increased significantly.
- Subjects :
- Male
Pediatrics
medicine.medical_specialty
Referral
030209 endocrinology & metabolism
Disease
Thyroid Carcinoma, Anaplastic
Risk Assessment
Disease-Free Survival
Patient Care Planning
Anaplastic thyroid carcinoma
03 medical and health sciences
0302 clinical medicine
Multidisciplinary approach
medicine
Humans
Thyroid Neoplasms
Anaplastic thyroid cancer
Thyroid cancer
Academic Medical Centers
business.industry
Biopsy, Needle
medicine.disease
Combined Modality Therapy
Immunohistochemistry
Quality Improvement
Survival Analysis
United States
Surgery
Clinical trial
Treatment Outcome
Otorhinolaryngology
030220 oncology & carcinogenesis
Critical Pathways
Thyroidectomy
Female
Interdisciplinary Communication
Radiotherapy, Adjuvant
business
Subjects
Details
- ISSN :
- 10433074
- Volume :
- 39
- Database :
- OpenAIRE
- Journal :
- Head & Neck
- Accession number :
- edsair.doi.dedup.....786ac36cc2ef25482ba8f71f00c5d305